Recursion Pharmaceuticals (RXRX) closed the most recent trading day at $3.18, moving -3.34% from the previous trading session. The stock's performance was behind the S&P 500's daily loss of 0.57%.
Microsoft, meanwhile, is trying to turn the trend towards recursive self-improvement into a sales pitch for enterprise AI. In ...
Recursion Pharmaceuticals combines artificial intelligence, automation, and biotechnology research across multiple ...
AI systems are already writing the code used to build better AI. Researchers are now asking whether that feedback loop could ...
On June 24, 2026, Microsoft’s Digital Crimes Unit (DCU) facilitated the takedown, suspension, and blocking of domains that ...
The companies at the frontier of artificial intelligence should be ready to slow down, one of the fastest-moving among them says. Anthropic, the maker of the Claude chatbot, has claimed AI systems may ...
Governments currently lack the frameworks, technical expertise, and speed to evaluate and regulate such advanced AI. The ...
The current calendar covers exhibitions dedicated to Brâncuşi’s legacy, highlights from the collections of local museums, and ...
Over six weeks in 2024, about 800 senior secondary students in Edo State sat in computer labs twice a week and learned English with the help of Microsoft ...
Robots and AI are running experiments around the clock, from battery chemistry to cancer therapies. But can they be trusted ...
The compiler infers, but does not take instructions. There is no syntax for explicit type declarations yet, and the new type ...
Wellbeing Magazine on MSN
Your anxiety isn’t a flaw. It’s your brain just trying to protect you
Have you ever grabbed something falling off a shelf before you even knew you were doing it? You didn't think about it. You ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results